CHASTIDY ROBB: Open Payments
NPI 1528541455 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 75 payments from 15 companies in 2025. Trend: 2023 $1,183 · 2024 $1,146 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $320 |
| Actelion Pharmaceuticals US, Inc. | 11 | $272 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $150 |
| Merck Sharp & Dohme LLC | 6 | $140 |
| JAZZ PHARMACEUTICALS INC. | 4 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Electromed, Inc. | 11 | $96 |
| Amgen Inc. | 3 | $80 |
| GENZYME CORPORATION | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $54 |
Products named: TEZSPIRE, DUPIXENT, OPSUMIT, ZERBAXA, XYWAV, OFEV, SMARTVEST, BREZTRI.
Industry payments across AL — which companies pay providers there.
